表观遗传变化是博特佐米布分子作用的重要方面
Piotr Kulig1, Karolina Łuczkowska1, Estera Bakinowska1
1Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.
Cancers
|January 11, 2024
概括
博尔特佐米布 (BTZ) 通过抑制蛋白质降解来治疗多发性髓瘤. 本综述探讨了BTZ诱导的表观遗传变化,影响其疗效,耐药性和副作用,并建议新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 博尔特佐米布 (BTZ) 是一种蛋白酶体抑制剂,对多发性骨髓瘤 (MM) 治疗至关重要.
- BTZ的机制涉及抑制20S蛋白酶体,导致蛋白质积累,增长抑制和亡.
- 除了蛋白酶抑制之外,BTZ还会诱导表观遗传变化,影响其治疗效果和耐药性.
研究的目的:
- 审查由Bortezomib (BTZ) 诱导的表观遗传变化.
- 检查与BTZ的作用机制,耐药性和外围神经病变相关的表观遗传修饰.
- 讨论针对表观遗传变化的治疗策略,以提高BTZ疗效或克服耐药性.
主要方法:
- 文献综述侧重于BTZ引起的表观遗传修饰.
- 对调查表观遗传改变对BTZ细胞毒性作用和耐药性的作用的研究进行分析.
- 对增强BTZ治疗的表观遗传剂的研究进行审查.
主要成果:
- 治疗BTZ会导致各种表观遗传变化.
- 这些变化有助于BTZ的细胞毒性,药物耐药性和外围神经病变的发展.
- 表观遗传修饰在对BTZ治疗的反应和耐药性方面发挥着重要作用.
结论:
- 表观遗传变化是博特佐米布在多发性骨髓瘤中的作用和耐药性的组成部分.
- 准这些表观遗传变异是一个有前途的治疗途径.
- 未来的策略可能涉及将表观遗传剂与BTZ结合起来,以改善患者的治疗结果.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K


